Is prophylaxis of venous thromboembolism (VTE) with low molecular weight heparin (LMWH) effective in hospitalized elderly oncology patients?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18761843
Cited by: 0

Abstract

LMWH is suggested for VTE prophylaxis in hospitalized oncology patients, though targeted evidence in elderly demographics remains limited. Further studies are needed to confirm its efficacy and safety in this specific group.

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Neutropenia and Cancer Infections

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
24 February 2026
Language
EN